Biomaterial Database

Relationship between serotype, sensitivity to ketoconazole and inhibition of pseudomycelial growth in Candida albicans. 1984

P Auger, and S Péloquin, and J Joly, and S Montplaisir, and G Marquis

UI	MeSH Term	Description	Entries
D007654	Ketoconazole	Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.	Nizoral,R-41400,R41,400,R41400,R 41400
D002176	Candida albicans	A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis).	Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177	Candidiasis	Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)	Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D004352	Drug Resistance, Microbial	The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).	Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005455	Fluorescent Antibody Technique	Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy.	Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012703	Serotyping	Process of determining and distinguishing species of bacteria or viruses based on antigens they share.	Serotypings

Related Publications

P Auger, and S Péloquin, and J Joly, and S Montplaisir, and G Marquis

Antigenic relationship between Candida parapsilosis and Candida albicans serotype B.

January 1984, Microbiology and immunology,

P Auger, and S Péloquin, and J Joly, and S Montplaisir, and G Marquis

Vascular clearance of blastospore and pseudomycelial phase Candida albicans.

July 1977, Sabouraudia,

P Auger, and S Péloquin, and J Joly, and S Montplaisir, and G Marquis

Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.

March 1984, Antimicrobial agents and chemotherapy,

P Auger, and S Péloquin, and J Joly, and S Montplaisir, and G Marquis

Inhibition of ergosterol synthesis in Candida albicans by ketoconazole [proceedings].

October 1979, Archives internationales de physiologie et de biochimie,

P Auger, and S Péloquin, and J Joly, and S Montplaisir, and G Marquis

Relationship between fluconazole sensitivity of Candida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count.

September 1994, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

P Auger, and S Péloquin, and J Joly, and S Montplaisir, and G Marquis

Entry of ketoconazole into Candida albicans.

February 1987, Antimicrobial agents and chemotherapy,

P Auger, and S Péloquin, and J Joly, and S Montplaisir, and G Marquis

Multifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans.

September 2021, Microbiology spectrum,

P Auger, and S Péloquin, and J Joly, and S Montplaisir, and G Marquis

Differences of asymmetrical division between the pseudomycelial and yeast forms of Candida albicans and their effect on multiplication.

June 1983, Archives of microbiology,

P Auger, and S Péloquin, and J Joly, and S Montplaisir, and G Marquis

Relationship of dermal and pulmonary sensitivity to extracts of Candida albicans.

September 1971, The American review of respiratory disease,